Laporte S A, Boucard A A, Servant G, Guillemette G, Leduc R, Escher E
Department of Pharmacology, Medical School, Université de Sherbrooke, Québec, Canada.
Mol Endocrinol. 1999 Apr;13(4):578-86. doi: 10.1210/mend.13.4.0270.
To identify ligand-binding domains of Angiotensin II (AngII) type 1 receptor (AT1), two different radiolabeled photoreactive AngII analogs were prepared by replacing either the first or the last amino acid of the octapeptide by p-benzoyl-L-phenylalanine (Bpa). High yield, specific labeling of the AT1 receptor was obtained with the 125I-[Sar1,Bpa8]AngII analog. Digestion of the covalent 125I-[Sar1,Bpa8]AngII-AT1 complex with V8 protease generated two major fragments of 15.8 kDa and 17.8 kDa, as determined by SDS-PAGE. Treatment of the [Sar1,Bpa8]AngII-AT1 complex with cyanogen bromide produced a major fragment of 7.5 kDa which, upon further digestion with endoproteinase Lys-C, generated a fragment of 3.6 kDa. Since the 7.5-kDa fragment was sensitive to hydrolysis by 2-nitro-5-thiocyanobenzoic acid, we circumscribed the labeling site of 125I-[Sar1,Bpa8]AngII within amino acids 285 and 295 of the AT1 receptor. When the AT1 receptor was photolabeled with 125I-[Bpa1]AngII, a poor incorporation yield was obtained. Cleavage of the labeled receptor with endoproteinase Lys-C produced a glycopeptide of 31 kDa, which upon deglycosylation showed an apparent molecular mass of 7.5 kDa, delimiting the labeling site of 125I-[Bpa1]AngII within amino acids 147 and 199 of the AT1 receptor. CNBr digestion of the hAT1 I165M mutant receptor narrowed down the labeling site to the fragment 166-199. Taken together, these results indicate that the seventh transmembrane domain of the AT1 receptor interacts strongly with the C-terminal amino acid of [Sar1, Bpa8]AngII interacts with the second extracellular loop of the AT1 receptor.
为了鉴定血管紧张素II(AngII)1型受体(AT1)的配体结合结构域,通过用对苯甲酰-L-苯丙氨酸(Bpa)取代八肽的第一个或最后一个氨基酸,制备了两种不同的放射性标记光反应性AngII类似物。用125I-[Sar1,Bpa8]AngII类似物获得了AT1受体的高产率、特异性标记。用V8蛋白酶消化共价125I-[Sar1,Bpa8]AngII-AT1复合物,通过SDS-PAGE测定产生了15.8 kDa和17.8 kDa的两个主要片段。用溴化氰处理[Sar1,Bpa8]AngII-AT1复合物产生了一个7.5 kDa的主要片段,该片段在用内肽酶Lys-C进一步消化后,产生了一个3.6 kDa的片段。由于7.5 kDa片段对2-硝基-5-硫氰基苯甲酸水解敏感,我们将125I-[Sar1,Bpa8]AngII的标记位点限定在AT1受体的285和295氨基酸之间。当用125I-[Bpa1]AngII对AT1受体进行光标记时,获得的掺入率较低。用内肽酶Lys-C切割标记的受体产生了一个31 kDa的糖肽,去糖基化后显示出7.5 kDa的表观分子量,将125I-[Bpa1]AngII的标记位点限定在AT1受体的147和199氨基酸之间。hAT1 I165M突变体受体的溴化氰消化将标记位点缩小到166-199片段。综上所述,这些结果表明,AT1受体的第七跨膜结构域与[Sar1,Bpa8]AngII的C末端氨基酸强烈相互作用,与AT1受体的第二个细胞外环相互作用。